COVID-19 Vaccination Is Safe among Mast Cell Disorder Patients, under Adequate Premedication

Reported cases of anaphylaxis following COVID-19 vaccination raised concerns about the safety of these vaccines, namely in patients suffering from clonal mast cell (MC) disorders—a heterogenous group of disorders in which patients may be prone to anaphylaxis caused by vaccination. This study aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Rama, Tiago Azenha, Miranda, Joana, Silva, Diana, Amaral, Luís, Castro, Eunice, Coimbra, Alice, Moreira, André, Plácido, José Luís
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146268/
https://www.ncbi.nlm.nih.gov/pubmed/35632474
http://dx.doi.org/10.3390/vaccines10050718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146268/
https://www.ncbi.nlm.nih.gov/pubmed/35632474
http://dx.doi.org/10.3390/vaccines10050718

Ejemplares similares